Women with a BRCA1 or BRCA2 mutation who have not chosen prophylactic salpingo-oophorectomy may follow determination of Ca125 and transvaginal ultrasound since age 35 (IIC), but they should be informed that early detection of ovarian cancer is not guaranteed. The gene discussed is BRCA2; the disease is ovarian carcinoma.